An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3′-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients

Introduction: Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor prescribed as part of first-line highly active antiretroviral therapy (HAART) in South Africa. Despite administration of fixed doses of EFV, inter-individual variability in plasma concentrations has been reported. Poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Swart, Marelize, Evans, Jonathan, Skelton, Michelle, Castel, Sandra, Wiesner, Lubbe, Smith, Peter J., Dandara, Collet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703773/
https://www.ncbi.nlm.nih.gov/pubmed/26779253
http://dx.doi.org/10.3389/fgene.2015.00356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703773/
https://www.ncbi.nlm.nih.gov/pubmed/26779253
http://dx.doi.org/10.3389/fgene.2015.00356

Ejemplares similares